# 510(k) Summary

# Introduction

According to the requirements of 21 CFR 807.92, the following information provides sufficient detail to understand the basis for a determination of substantial equivalence.

# Submitter Name, Address, Contact

Roche Diagnostics 9115 Hague Road Indianapolis, IN 46250 (317) 521-2458

Contact Person: Michael Leuther, PhD, MBA

Date Prepared: July 18, 2012

# Device Name

Proprietary name:

(1) Elecsys Vitamin D Assay )Elecsys Vitamin D CalSet (3) Elecsys PreciControl Varia 3 (4) Elecsys Vitamin D CalCheck 5

Common name:

(1) Vitamin D Assay Vitamin D Calibrator )Vitamin D Control (4) Vitamin D CalCheck 5

Classification name: (1) System, Test, Vitamin D (2) Calibrator, Secondary (3) Multi-analyte controls, all kinds (Assayed and Unassayed) (4) Single (specified) analyte controls (Assayed and Unassayed

# Device Description

(1) The Elecsys Vitamin D Assay is a competitive protein binding assay which uses Vitamin D Binding Protein instead of monoclonal antibodies for detection of 25-Hydroxyvitamin D. The total duration of the assay is 27 minutes. The sample is treated with pretreatment reagent in the first incubation period. This releases any vitamin D from the endogenous vitamin D binding protein present in the patient's sample. In the next incubation, vitamin D binding protein labeled with ruthenium is added and a complex is formed between the vitamin D (25- OH) and the ruthenylated vitamin D binding protein. In the $3 ^ { \mathsf { r d } }$ and final incubation, streptavidin-coated microparticles are added along with vitamin D (25-OH) labeled with biotin. Any unbound ruthenium labeled vitamin D binding proteins become occupied with biotin-labeled vitamin D (25-OH). The complex consisting of the ruthenylated vitamin D binding protein and the biotinylated vitamin D (25-OH) becomes bound to the solid phase via interaction of the biotin and streptavidin. The reaction mixture is aspirated into the measuring cell where the electrochemiluminescence emission is detected. Results are determined using a calibration curve that is generated specifically on each instrument by a 2 point calibration provided with the reagent bar code.

(2) The Elecsys Vitamin D CalSet is a lyophilized product based on human serum. It has been standardized against LC-MS/MS, which has in turn been standardized to the NIST standard. .

(3) The Elecsys PreciControl Varia 3 is a multi-composite lyophilized 3 level control set which has been previously cleared for 7 components . The Elecsys PreciControl Varia 3 has been cleared under K11 1506 for the following analytes:

<table><tr><td rowspan=1 colspan=1>Assay Name</td><td rowspan=1 colspan=1>FDA Clearance Number forReagents</td></tr><tr><td rowspan=1 colspan=1>Vitamin B12</td><td rowspan=1 colspan=1>K060755</td></tr><tr><td rowspan=1 colspan=1>Ferritin</td><td rowspan=1 colspan=1>K971833</td></tr><tr><td rowspan=1 colspan=1>Folate III</td><td rowspan=1 colspan=1>K082340</td></tr><tr><td rowspan=1 colspan=1>βCrossLaps/Serum ( -CTx)</td><td rowspan=1 colspan=1>K993706</td></tr><tr><td rowspan=1 colspan=1>Osteocalcin</td><td rowspan=1 colspan=1>K051297</td></tr><tr><td rowspan=1 colspan=1>Parathyroid Hormone</td><td rowspan=1 colspan=1>K070709</td></tr><tr><td rowspan=1 colspan=1>Parathyroid Hormone ShortTurnaround Time (PTH-STAT)</td><td rowspan=1 colspan=1>K070709</td></tr></table>

(4) The Elecsys Vitamin D CalCheck 5 contains 5 lyophilized levels based on human serum.

Note: The reagent, calibrator, and the quality control materials are all packaged separately.

# 510(k) Summary, Continued

Intended   
Use/Indications   
for Use

# Elecsys Vitamin D Reagent:

The Elecsys Vitamin D assay is intended for the quantitative determination of total 25-hydroxyvitamin D in human serum and plasma. The assay is to be used as an aid in the assessment of vitamin D sufficiency in adults.

The electrochemiluminescence binding assay is intended for use on Elecsys and cobas e immunoassay analyzers.

Elecsys Vitamin D CalSet: Elecsys Vitamin D CalSet is used for calibrating the quantitative Elecsys Vitamin D assay on the Elecsys and cobas e immunoassay analyzers.

Elecsys PreciControl Varia 3: Elecsys PreciControl Varia 3 is used for quality control of the specified Elecsys immunoassays on the Elecsys and cobas e immunoassay analyzers.

Elecsys Vitamin D CalCheck 5: The Elecsys Vitamin D CalCheck 5 is an assayed control for use in calibration verification and for use in the verification of the assay range established by the Elecsys Vitamin D reagent on the indicated Elecsys and cobas e immunoassay analyzers.

# 510(k) Summary, Continued

# Substantial Equivalence

The Elecsys Vitamin D Test System is substantially equivalent to other devices legally marketed in the United States.

(1) Elecsys Vitamin D Assay is equivalent to the Abbott Architect 25-OH Vitamin D assay (K110619).

(2) Elecsys Vitamin D CalSet is equivalent to the standards contained in the Elecsys hGH CalSet (K103221) (Human Growth Hormone).

(3) Elecsys PreciControl Varia 3 is equivalent to the controls contained in the PreciControl Multimarker (K102157).

(4) The Elecsys Vitamin D CalCheck 5 is equivalent to the Elecsys T4 CalCheck 5 (K112528).

Elecsys Vitamin D 510(K) Submission

# Premarket Notification, 510(k) for Elecsys Vitamin D Test System

Substantial Equivalence - Comparison

The following table compares the Elecsys Vitamin D Test System with the predicate device. The next three tables compare the Elecsys Vitamin D CalSet, CalCheck 5, and PreciControl Varia 3 to their predicates.

# Comparison of Assays, Similarities and Differences Premarket Notification, 510(k) for Elecsys Vitamin D Test System

<table><tr><td rowspan=1 colspan=3>Assay Comparison</td></tr><tr><td rowspan=1 colspan=1>Feature</td><td rowspan=1 colspan=1>Elecsys Vitamin D Assay</td><td rowspan=1 colspan=1>Predicate Device: Abbott Architect25-OH Vitamin D(K110619)</td></tr><tr><td rowspan=1 colspan=3>General Assay Features</td></tr><tr><td rowspan=1 colspan=1>IntendedUse/Indicationsfor Use</td><td rowspan=1 colspan=1>The Vitamin D assay is intended forthe quantitative determination of total25-hydroxyvitamin D in human serumand plasma. This assay is to be usedas an aid in the assessment of vitaminD sufficiency in adults.The electrochemiluminescencebinding assay is intended for use onElecsys and cobas e immunoassayanalyzers.</td><td rowspan=1 colspan=1>The Abbott Architect 25-OH VitaminD assay is a chemiluminescentmicroparticle immunoassay (CMIA)for the quantitative determination of25-hydroxyvitamin D (25-OH vitaminD) in human serum or plasma. TheArchitect 25-OH Vitamin D assay is tobe used as an aid in the assessment ofvitamin D sufficiency.</td></tr><tr><td rowspan=1 colspan=1>AssayProtocol</td><td rowspan=1 colspan=1>Quantitative protein binding assay</td><td rowspan=1 colspan=1>Quantitative chemiluminescenceimmunoassay</td></tr><tr><td rowspan=1 colspan=1>DetectionProtocol</td><td rowspan=1 colspan=1>Electrochemiluminescence</td><td rowspan=1 colspan=1>Chemiluminescence</td></tr><tr><td rowspan=1 colspan=1>Applications</td><td rowspan=1 colspan=1>27 minute application</td><td rowspan=1 colspan=1>36 minutes (time to first result)</td></tr></table>

# Premarket Notification, 510(k) for Elecsys Vitamin D Test System, Continued

Comparison of Assays—Similarities and Differences, continued   

<table><tr><td rowspan=1 colspan=3>Assay Comparison</td></tr><tr><td rowspan=1 colspan=1>Feature</td><td rowspan=1 colspan=1>Elecsys Vitamin D Assay</td><td rowspan=1 colspan=1>Predicate Device: AbbottArchitect 25-OH Vitamin D(K110619)</td></tr><tr><td rowspan=1 colspan=3>General Assay Features                                  &#x27;</td></tr><tr><td rowspan=1 colspan=1>InstrumentPlatform</td><td rowspan=1 colspan=1>Elecsys 2010 and cobas e 411</td><td rowspan=1 colspan=1>Abbott Architect 25-OH Vitamin D</td></tr><tr><td rowspan=1 colspan=1>SampleVolume</td><td rowspan=1 colspan=1>15 μL</td><td rowspan=1 colspan=1>60 μL for first run, 10 μL foradditional runs</td></tr><tr><td rowspan=1 colspan=1>SampleType</td><td rowspan=1 colspan=1>Human serum and plasma treated withK2-EDTA, K3-EDTA or lithiumheparin.</td><td rowspan=1 colspan=1>Human serum, plasma treated withlithium heparin, sodium heparin,potassium EDTA, or sodium citrate.</td></tr><tr><td rowspan=1 colspan=1>Reagents</td><td rowspan=1 colspan=1>The Elecsys Vitamin D assay is acompetitive binding assay whichincludes vitamin D (25-OH) labeledwith biotin, and a ruthenium labeledvitamin D binding protein, andstreptavidin coated microparticles.</td><td rowspan=1 colspan=1>The Abbott Architect 25-OH VitaminD assay is a competitive one-stepdelayed immunometric assay whichincludes anti-vitamin D coatedmicroparticles, an assay diluent, andbiotinylated vitamin D anti-biotinacridinium labeled conjugate.</td></tr><tr><td rowspan=1 colspan=1>Calibrator</td><td rowspan=1 colspan=1>Elecsys Vitamin D CalSet, 2 levels</td><td rowspan=1 colspan=1>Architect 25-OH Vitamin DCalibrators, 6 levels</td></tr></table>

# Premarket Notification, 510(k) for Elecsys Vitamin D Test System, Continued

Comparison of Assays—Similarities and Differences, continued   

<table><tr><td colspan="3">Assay Comparison</td></tr><tr><td>Feature</td><td>Elecsys Vitamin D Assay</td><td>Predicate Device: Abbott Architect 25-OH Vitamin D (K110619)</td></tr><tr><td colspan="3">General Assay Features</td></tr><tr><td>Calibration Interval</td><td>Calibration must be performed once per reagent lot using fresh reagent (i.e. not more than 24 hours since the reagent kit was registered on the analyzer). Renewed calibration is recommended as follows: • After 1 month (28 days) when using the same reagent lot. After 7 days (when using the • same reagent kit on the analyzer). • As required: e.g. quality control findings outside the</td><td>Calibration must be performed: After 7 days When a control value is out of range</td></tr><tr><td>Controls</td><td>specified limits Elecsys PreciControl Varia 3</td><td>Architect 25-OH Vitamin D Controls</td></tr></table>

# Premarket Notification, 510(k) for Elecsys Vitamin D Test System, Continued

Comparison of Assays—Similarities and Differences, continued   

<table><tr><td rowspan=1 colspan=3>Assay Comparison</td></tr><tr><td rowspan=1 colspan=1>Feature</td><td rowspan=1 colspan=1>Elecsys Vitamin D Assay</td><td rowspan=1 colspan=1>Predicate Device: AbbottArchitect 25-OH Vitamin D(K110619)</td></tr><tr><td rowspan=1 colspan=3>General assay features</td></tr><tr><td rowspan=1 colspan=1>Traceability /Standardization</td><td rowspan=1 colspan=1>The Elecsys Vitamin D Assay hasbeen standardized against LC-MS/MSwhich in turn has been standardized tothe NIST standard.</td><td rowspan=1 colspan=1>Architect 25-OH Vitamin D istraceable to a manufacturer&#x27;sinternal standard (PrimaryCalibrator), which is anchoredagainst Absorbance at 264 nm.</td></tr><tr><td rowspan=1 colspan=1>ReagentStability</td><td rowspan=1 colspan=1>Unopened at 2-8 °C-up to statedexpiration dateAfter opening at 2-8 °C—56 daysOn the Elecsys 2010 and cobas e411--21 days</td><td rowspan=1 colspan=1>Unopened at 2-8 °C—up to statedexpiration date.After opening: on-board theanalyzer for 14 days</td></tr></table>

# Premarket Notification, 510(k) for Elecsys Vitamin D Test

System, Continued Comparison of Assays—Similarities and Differences, continued

<table><tr><td rowspan=1 colspan=3>Assay Comparison</td></tr><tr><td rowspan=1 colspan=1>Feature</td><td rowspan=1 colspan=1>Elecsys Vitamin D Assay</td><td rowspan=1 colspan=1>Predicate Device: AbbottArchitect 25-OH Vitamin D(K110619)</td></tr><tr><td rowspan=1 colspan=3>Labeled Performance Characteristics</td></tr><tr><td rowspan=1 colspan=1>MeasuringRange</td><td rowspan=1 colspan=1>5-60 ng/mL</td><td rowspan=1 colspan=1>13-96 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Precision</td><td rowspan=1 colspan=1>Elecsys 2010/ cobas e 411:Within-run (will be labeled Repeatability)n=84, human sera7.2% CV @  6.2 ng/mL5.1% CV @  11.2 ng/mL2.9% CV @  23.2 ng/mL2.4% CV @  45.3ng/mL1.6% CV @  52.6 ng/mLTotal (will be labeled Intermediate)10.3% CV @  6.2 ng/mL7.6% CV @  11.2 ng/mL5.3% CV @  23.2 ng/mL3.4% CV @  45.3ng/mL2.9% CV @  52.6 ng/mL</td><td rowspan=1 colspan=1>Abbott Architect 25-OH Vitamin DWithin-runn=80, human sera3.1% CV @    23.0 ng/mL2.6% CV @     42.5 ng/mL1.4% CV @     75.4 ng/mLTotal4.0% CV @    23.0 ng/mL3.2% CV @     42.5 ng/mL2.7% CV @     75.4 ng/mL</td></tr></table>

# Premarket Notification, 510(k) for Elecsys Vitamin D Test System, Continued

Comparison of Assays—Similarities and Differences, continued   

<table><tr><td rowspan=1 colspan=8>Assay Comparison</td></tr><tr><td rowspan=1 colspan=1>Feature</td><td rowspan=1 colspan=4>Elecsys Vitamin D Assay</td><td rowspan=1 colspan=3>Predicate Device: AbbottArchitect 25-OH Vitamin D(K110619)</td></tr><tr><td rowspan=1 colspan=8>Labeled Performance Characteristics</td></tr><tr><td rowspan=1 colspan=1>AnalyticalSensitivity</td><td rowspan=1 colspan=4>Limit of Blank (LoB) 2.00 ng/mLLimit of Detection (LoD) 3.00 ng/mLLimit of Quantitation (LoQ) 5.00ng/mL</td><td rowspan=1 colspan=3>Limit of Blank: 1.9 ng/mLLimit of Detection: 3.1 ng/mLLLimit of Quantitation (LoQ) 8.0ng/mL</td></tr><tr><td rowspan=14 colspan=1>AnalyticalSpecificity</td><td></td><td rowspan=1 colspan=1>Cross Reactant</td><td rowspan=1 colspan=1>CrossReactivity(%)</td><td></td><td rowspan=1 colspan=2>Cross Reactant</td><td rowspan=1 colspan=1>CrossReactivity(%)</td></tr><tr><td></td><td rowspan=1 colspan=1>25-hydroxyvitamin D3</td><td rowspan=1 colspan=1>100</td><td></td><td></td><td rowspan=1 colspan=1>25-hydroxyvitamin D3</td><td rowspan=1 colspan=1>105</td></tr><tr><td></td><td rowspan=1 colspan=1>25-hydroxyvitamin D2</td><td rowspan=1 colspan=1>92</td><td></td><td></td><td rowspan=1 colspan=1>25-hydroxyvitamin D2</td><td rowspan=1 colspan=1>82</td></tr><tr><td></td><td rowspan=1 colspan=1>24,25-hydroxyvitamin D3</td><td rowspan=1 colspan=1>149</td><td></td><td></td><td rowspan=1 colspan=1>24,25-hydroxyvitamin D3</td><td rowspan=1 colspan=1>112</td></tr><tr><td></td><td rowspan=2 colspan=1>1,25-hydroxyvitamin D3</td><td rowspan=2 colspan=1>not detected</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td rowspan=2 colspan=1>1,25-hydroxyvitamin D3</td><td rowspan=2 colspan=1>12.6</td></tr><tr><td></td><td rowspan=2 colspan=1>1,25-hydroxyvitamin D2</td><td rowspan=2 colspan=1>not detected</td><td></td><td></td></tr><tr><td></td><td></td><td></td><td rowspan=2 colspan=1>1,25-hydroxyvitamin D2</td><td rowspan=2 colspan=1>Not tested</td></tr><tr><td></td><td rowspan=1 colspan=1>Vitamin D3</td><td rowspan=1 colspan=1>not detected</td><td></td><td></td></tr><tr><td></td><td rowspan=2 colspan=1>Vitamin D2</td><td rowspan=2 colspan=1>not detected</td><td rowspan=2 colspan=1></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td rowspan=1 colspan=1>Vitamin D3</td><td rowspan=1 colspan=1>0.3</td></tr><tr><td></td><td rowspan=2 colspan=1>C3-epimer of 25-hydroxyvitamin D3</td><td rowspan=2 colspan=2>91</td><td></td><td rowspan=1 colspan=1>Vitamin D2</td><td rowspan=1 colspan=1>0.1</td></tr><tr><td></td><td rowspan=2 colspan=2>C3-epimer of 25-hydroxyvitamin D3</td><td rowspan=2 colspan=1>2.7</td></tr><tr><td rowspan=1 colspan=4>EY</td></tr><tr><td rowspan=1 colspan=1>Hook Effect</td><td rowspan=1 colspan=4>There is no high-dose hook effectsince the Elecsys Vitamin D assay is acompetitive assay</td><td rowspan=1 colspan=3>Unknown</td></tr><tr><td rowspan=1 colspan=1>Limitations</td><td rowspan=1 colspan=4>The assay is unaffected by:Hemoglobin &lt; 2 g/LBilirubin up ≤ 66 mg/dLLipemia &lt; 400 mg/dLBiotin &lt; 70 ng/mLHAMA and Rheumatoid factors werenot assessed because the assay does notutilize antibodies</td><td rowspan=1 colspan=3>The assay is unaffected by:Hemoglobin &lt;200 mg/dLBilirubin up &lt; 20 mg/dLTriglycerides &lt; 5000 mg/dLBiotin not testedHAMA&lt;1000 ng/mLRheumatoid Factor &lt;400 IU/mL</td></tr></table>

# Premarket Notification, 510(k) for Elecsys Vitamin D Test

System, Continued Comparison of Assays—Similarities and Differences, continued

<table><tr><td rowspan=1 colspan=7>Assay Comparison</td></tr><tr><td rowspan=1 colspan=1>Feature</td><td rowspan=1 colspan=4>Elecsys Vitamin D Assay</td><td rowspan=1 colspan=2>Predicate Device: AbbottArchitect 25-OH Vitamin D(K110619)</td></tr><tr><td rowspan=1 colspan=7>Labeled Performance Characteristics</td></tr><tr><td rowspan=3 colspan=1>MethodComparison(LC-MS/MSvs. Elecsys)</td><td rowspan=3 colspan=6>Slope              Intercept               rDeming(n=290)           1.03                  -3.07                0.85</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=2>Intercept</td><td rowspan=1 colspan=1>r</td></tr><tr><td rowspan=1 colspan=1>Deming(n=290)</td><td rowspan=1 colspan=1>1.03</td><td rowspan=1 colspan=2>-3.07</td><td rowspan=1 colspan=1>0.85</td></tr><tr><td rowspan=3 colspan=1>MethodComparisonAbbott vs.Elecsys)</td><td rowspan=3 colspan=6>Slope              Intercept                rDeming(n=165)           0.99                   1.20                 0.91</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=2>Intercept</td><td rowspan=1 colspan=1>r</td></tr><tr><td rowspan=1 colspan=1>Deming(n=165)</td><td rowspan=1 colspan=1>0.99</td><td rowspan=1 colspan=2>1.20</td><td rowspan=1 colspan=1>0.91</td></tr></table>

# Premarket Notification, 510(k) for Elecsys Vitamin D Test

System, Continued Comparison of CalSet Materials

<table><tr><td rowspan=1 colspan=1>Characteristic</td><td rowspan=1 colspan=1>CalSet for Elecsys Vitamin D Assay</td><td rowspan=1 colspan=1>Predicate Device: Elecsys hGHCalSet (K103221)</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>Elecsys Vitamin D CalSet is used forcalibrating the quantitative ElescysVitamin D assay on the Elecsys andcobas e immunoassay analyzers.</td><td rowspan=1 colspan=1>Elecsys hGH CalSet is used forcalibrating the quantitative ElecsyshGH assay on the Elecsys andcobas e immunoassay analyzers.</td></tr><tr><td rowspan=1 colspan=1>Levels</td><td rowspan=1 colspan=1>Two</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Matrix</td><td rowspan=1 colspan=1>Human serum</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Format</td><td rowspan=1 colspan=1>Lyophilized</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Stability</td><td rowspan=1 colspan=1>Unopened:Store at 2 - 8°C up to the statedexpiration date.After reconstitution:At 2 - 8°C: 120 hoursAt -20°C: 90 days (freeze onlyonce).•On Elecsys 2010/cobas e 411 at 20- 25°C: Up to 5 hours.</td><td rowspan=1 colspan=1>Unopened:Store at 2 - 8°C up to the statedexpiration date.After reconstitution:At 2 - 8°C: 7 daysAt -20°C: 28 days (freeze onlyonce). On Elecsys 2010/cobas e 41 1 at20 - 25°C: Up to 5 hours.On MODULAR ANALYTICSE170/cobas e 601: Use only once.</td></tr><tr><td rowspan=1 colspan=1>Handling</td><td rowspan=1 colspan=1>Dissolve the contents of one bottlecarefully by adding exactly 1.0 mL ofdistilled water and allow to standclosed for 15 minutes to reconstitute.Mix carefully, avoiding the formationof foam. Transfer the reconstitutedcalibrator into the empty labeled snap-cap bottles supplied.</td><td rowspan=1 colspan=1>Dissolve carefully the contents ofone bottle by adding exactly 1.0 mLof distilled or deionized water andallow to stand closed for 15 minutesto reconstitute. Mix carefully,avoiding the formation of foam.Transfer the reconstituted calibratorinto the empty labeled snap-capbottle supplied.</td></tr></table>

# Premarket Notification, 510(k) for Elecsys Vitamin D Test

System, Continued Comparison of PreciControl Materials

<table><tr><td rowspan=1 colspan=1>Characteristic</td><td rowspan=1 colspan=1>Elecsys PreciControl Varia 3</td><td rowspan=1 colspan=1>Predicate Device:Elecsys PreciControlMultimarker (K102157)</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>Elecsys PreciControl Varia 3 is used forquality control of Elecsys immunoassayson the Elecsys and cobas e immunoassayanalyzers.</td><td rowspan=1 colspan=1>Elecsys PreciControl Multimarker isused for quality control of specifiedElecsys immunoassays on the Elecsysand cobas e immunoassay analyzers.</td></tr><tr><td rowspan=1 colspan=1>Levels</td><td rowspan=1 colspan=1>Three</td><td rowspan=1 colspan=1>Two</td></tr><tr><td rowspan=1 colspan=1>Format</td><td rowspan=1 colspan=1>Lyophilized</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Matrix</td><td rowspan=1 colspan=1>Human serum</td><td rowspan=1 colspan=1>Equine serum</td></tr><tr><td rowspan=1 colspan=1>AnalyteConcentration</td><td rowspan=1 colspan=1>25-hydroxyvitamin D (synthetic) inhuman serum at target values ofapproximately:V3 0: 12.8 ng/mLV3 1: 17 ng/mLV3 2: 32 ng/mL</td><td rowspan=1 colspan=1>C-Peptide (synthetic): Approximately2 and 10 ng/mL.Insulin (human recombinant fromyeast): Approximately 25 and 80μU/mL.ACTH (synthetic): Approximately 50and 1,000 pg/mL.hGH (human recombinant from E.coli): Approximately 1 and 10 ng/mL.</td></tr><tr><td rowspan=1 colspan=1>Stability</td><td rowspan=1 colspan=1>Unopened:Store at 2-8°C up to the statedexpiration dateReconstituted:2 - 8C: 72 hours-20°C: 31 days(freeze only once)On the analyzers at 20-25°C: up to 5hours</td><td rowspan=1 colspan=1>Unopened:Store at 2-8°C up to the statedexpiration dateReconstituted:2 - 8°C: 72 hours-20°C: 31 days (freeze only once)On the analyzers at 20-25°C: up to5 hours</td></tr><tr><td rowspan=1 colspan=1>Handling</td><td rowspan=1 colspan=1>Carefully dissolve the contents of onebottle by adding exactly 3.0 mL ofdistilled or deionized water and allow tostand closed for 30 minutes toreconstitute. Mix carefully, avoiding theformation of foam. Transfer thereconstituted control into the empty,labeled snap-cap bottles supplied orfreeze aliquots in additional snap-capbottles (ControlSet Vials). Attach thesupplied labels to these bottles. Performonly one control procedure per aliquot.</td><td rowspan=1 colspan=1>Dissolve carefully the contents of onebottle by adding exactly 2.0 mL ofdistilled or deionized water and allowto stand closed for 30 minutes toreconstitute. Mix carefully, avoidingthe formation of foam. Transfer thereconstituted control into empty,labeled snap-cap bottles supplied(ControlSet Vials) and freeze aliquotsimmediately in additional ControlSetVials. Attach the supplied labels tothese additional bottles. Perform onlyone control procedure per aliquot.</td></tr></table>

# Premarket Notification, 510(k) for Elecsys Vitamin D Test

System, Continued Comparison of CalCheck 5 Materials

<table><tr><td rowspan=1 colspan=1>Characteristic</td><td rowspan=1 colspan=1>Elecsys Vitamin D CalCheck 5</td><td rowspan=1 colspan=1>Predicate Device:Elecsys T4 CalCheck 5 (K112528)</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>The Elecsys Vitamin D CalCheck 5 is anassayed control for use in calibrationverification and for use in the verificationof the assay range established by theElecsys Vitamin D reagent on theindicated Elecsys and cobas eimmunoassay analyzers.</td><td rowspan=1 colspan=1>The Elecsys T4 CalCheck 5 is anassayed control for use in calibrationverification and for use in theverification of the assay rangeestablished by the Elecsys T4 reagenton the indicated Elecsys and cobas eimmunoassay analyzers.</td></tr><tr><td rowspan=1 colspan=1>Analyte</td><td rowspan=1 colspan=1>(25-OH) Vitamin D</td><td rowspan=1 colspan=1>Thyroxine (T4)</td></tr><tr><td rowspan=1 colspan=1>Levels</td><td rowspan=1 colspan=1>Five</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Matrix</td><td rowspan=1 colspan=1>Human serum</td><td rowspan=1 colspan=1>Check 1: BSA/Buffer matrixCheck 2-5: human serum</td></tr><tr><td rowspan=1 colspan=1>Format</td><td rowspan=1 colspan=1>Lyophilized</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Handling</td><td rowspan=1 colspan=1>Reconstitute Check 1, Check 2, Check 3,Check 4 and Check 5 with exactly 1.0 mLdistilled or deionized water. Allow tostand closed for 15 minutes, then mixgently by inversion to ensurehomogeneity.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Stability</td><td rowspan=1 colspan=1>Unopened:•  Store at 2-8 °C until expirationdateReconstituted:•20-25 °C: 5 hours</td><td rowspan=1 colspan=1>Same</td></tr></table>

# JUL 2 4 2012

Roche Diagnostics   
c/o Michael Leuther, PhD, MBA   
Roche Professional Diagnostics   
9115 Hague Road   
Indianapolis, IN 46250   
RE: k113546   
Trade Name: Elecsys Vitamin D Assay Elecsys Vitamin D CalSet Elecsys PreciControl Varia 3 Elecsys Vitamin D Calchek 5   
Regulation Number: 21 CFR $\ S 8 6 2 . 1 8 2 5$   
Regulation Name: Vitamin D test system   
Regulatory Class: Class II   
Product Codes: MRG, JIT,JJY,JJX   
Dated: July 5, 2012   
Received: July 6, 2012

Dear Dr. Leuther:

We have reviewed your Section $5 1 0 ( \mathbf { k } )$ premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

Page 2

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (301) 796-5760. For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/Medical   
Devices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance...

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-5680 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm

Sincerely yours,

2L

Coupney H. Lias, Ph.D.   
Director   
Division of Chemistry and Toxicology Devices Office of In Vitro Diagnostic Device   
Evaluation and Safety   
Center for Devices and Radiological Health

# Elecsys Vitamin D 510(K) Submission

# Indications for Use Form

510(k) Number (if known):

Device Name: Elecsys Vitamin D Assay

Indications for Use:

The Elecsys Vitamin D assay is intended for the quantitative determination of total 25-hydroxy vitamin D in human serum and plasma. The Elecsys Vitamin D assay is to be used as an aid in the assessment of vitamin D sufficiency in adults.

The electrochemiluminescence binding assay is intended for use on Elecsys and cobas e immunoassay analyzers.

AND/OR O(ver-The-Coutep use)

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

C

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

# Elecsys Vitamin D 510(K) Submission

# Confidential

# Indications for Use Form

510(k) Number (if known):

Device Name: __Elecsys Vitamin D CalSet

Indications for Use: Elecsys Vitamin D CalSet is used for calibrating the quantitative Elecsys Vitamin D assay on the Elecsys and cobas e immunoassay analyzers.

( ion U Subpr D AND/OR (ver-The-Coust ust)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED) 1

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

![](images/905b9d1b9a4329d497e6fe413da2b4625cc9cde8386d322cc974a06f96089375.jpg)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

510(k) K113546

# Elecsys Vitamin D 510(K) Submission

Confidential

# Indications for Use Form

510(k) Number (if known):

Device Name: Elecsys PreciControl Varia 3

Indications for Use: Elecsys PreciControl Varia 3 is used for quality control of specified Elecsys immunoassays on Elecsys and cobas e immunoassay analyzers.

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

Cah 0

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

510(k) 1113546

# Elecsys Vitamin D 510(K) Submission

# Confidential

Page 1 of

# Indications for Use Form

510(k) Number (if known):

Device Name: Elecsys Vitamin D CalCheck 5

Indications for Use: The Elecsys Vitamin D CalCheck 5 is an assayed control for use in calibration verification and for use in the verification of the assay range established by the Elecsys Vitamin D reagent on the indicated Elecsys and cobas e immunoassay analyzers.

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

![](images/ea288563c4cdbaf92fe3d00d9602ed2114e1bb2a735e7a2b1eaa28c141747445.jpg)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

510(k) k113546